Sixteen of the Dow’s 30 stocks are up at least 10% this year. Two are Johnson & Johnson (NYSE: JNJ) and Merck (NYSE: MRK), a combined 15.1% of VHT’s weight at the end November.
“Protecting profits as VHT looks to accelerate a move to test the top of its 2011 price (log) uptrend channel does begin to pose some issues as strong supports look to be further and further away with its refusal to pause or pull back. Initial support is now near 120 or the Sep. 2014 high and the Oct. 2014 breakout. The bottom of the trend channel closer to 115 represents key secondary support,” according to J. Beck Investments.
Last week, Vanguard lowered the fees on VHT to 0.12% per year, moving the fund into a tie with the Fidelity MSCI Health Care Index ETF (NYSEArca: FHLC) for the title of cheapest health care ETF. [Vanguard Cuts Fees on Sector ETFs]
Vanguard Health Care ETF
